{"id":"https://openalex.org/W4362592053","doi":"https://doi.org/10.1158/1541-7786.22515198","title":"Supplemental Table 2 from PRAS40 Phosphorylation Correlates with Insulin-Like Growth Factor-1 Receptor-Induced Resistance to Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells","display_name":"Supplemental Table 2 from PRAS40 Phosphorylation Correlates with Insulin-Like Growth Factor-1 Receptor-Induced Resistance to Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362592053","doi":"https://doi.org/10.1158/1541-7786.22515198"},"language":"en","primary_location":{"id":"doi:10.1158/1541-7786.22515198","doi":"https://doi.org/10.1158/1541-7786.22515198","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.22515198","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1541-7786.22515198","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076362284","display_name":"Michael I. Dougherty","orcid":"https://orcid.org/0000-0003-3682-336X","observed_orcids":["https://orcid.org/0000-0003-3682-336X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael I. Dougherty","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3682-336X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046183492","display_name":"Christine E. Lehman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christine E. Lehman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103130139","display_name":"Adam Spencer","orcid":"https://orcid.org/0009-0002-9353-429X","observed_orcids":["https://orcid.org/0009-0002-9353-429X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam Spencer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044032013","display_name":"Rolando E. Mendez","orcid":"https://orcid.org/0000-0003-3335-2347","observed_orcids":["https://orcid.org/0000-0003-3335-2347"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rolando E. Mendez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082177422","display_name":"Abel P. David","orcid":"https://orcid.org/0000-0003-1687-8240","observed_orcids":["https://orcid.org/0000-0003-1687-8240"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abel P. David","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1687-8240","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023901142","display_name":"Linnea E. Taniguchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linnea E. Taniguchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110689423","display_name":"Julie Wulfkuhle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julie Wulfkuhle","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023762376","display_name":"Emanuel F. Petricoin","orcid":"https://orcid.org/0000-0001-9146-5572","observed_orcids":["https://orcid.org/0000-0001-9146-5572"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emanuel F. Petricoin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089350105","display_name":"Daniel G. Gioeli","orcid":"https://orcid.org/0000-0003-2284-8152","observed_orcids":["https://orcid.org/0000-0003-2284-8152"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Gioeli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5082940788","display_name":"Mark J. Jameson","orcid":"https://orcid.org/0000-0002-7414-2779","observed_orcids":["https://orcid.org/0000-0002-7414-2779"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark J. Jameson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.5717999935150146,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.5717999935150146,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.27489998936653137,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.06729999929666519,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pras40-phosphorylation","display_name":"PRAS40 phosphorylation","score":0.9789999723434448},{"id":"https://openalex.org/keywords/igf-1-receptor","display_name":"IGF-1 receptor","score":0.9549999833106995},{"id":"https://openalex.org/keywords/egfr-inhibitor-resistance","display_name":"EGFR inhibitor resistance","score":0.7590000033378601},{"id":"https://openalex.org/keywords/head-and-neck-cancer","display_name":"head and neck cancer","score":0.7929999828338623},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.8640000224113464},{"id":"https://openalex.org/keywords/protein-signaling","display_name":"protein signaling","score":0.35499998927116394},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.3409999907016754},{"id":"https://openalex.org/keywords/phosphoproteomics","display_name":"phosphoproteomics","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C144174609","wikidata":"https://www.wikidata.org/wiki/Q14901457","display_name":"Insulin-like growth factor 1 receptor","level":4,"score":0.7577106952667236},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.7016589641571045},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5105810761451721},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.5050564408302307},{"id":"https://openalex.org/C2780689927","wikidata":"https://www.wikidata.org/wiki/Q24766801","display_name":"Insulin-like growth factor","level":4,"score":0.47851669788360596},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4776115119457245},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.46867427229881287},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4563501477241516},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4549616575241089},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.4479562044143677},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4287105202674866},{"id":"https://openalex.org/C26375932","wikidata":"https://www.wikidata.org/wiki/Q118226","display_name":"Growth factor receptor","level":3,"score":0.42120349407196045},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35885870456695557},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3382566273212433},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.33049526810646057},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.32039153575897217},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.25396835803985596},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.22820955514907837},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11871457099914551}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1541-7786.22515198","doi":"https://doi.org/10.1158/1541-7786.22515198","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.22515198","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1541-7786.22515198.v1","doi":"https://doi.org/10.1158/1541-7786.22515198.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.22515198.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22515198","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Supplemental_Table_2_from_PRAS40_Phosphorylation_Correlates_with_Insulin-Like_Growth_Factor-1_Receptor-Induced_Resistance_to_Epidermal_Growth_Factor_Receptor_Inhibition_in_Head_and_Neck_Cancer_Cells/22515198","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"}],"best_oa_location":{"id":"doi:10.1158/1541-7786.22515198","doi":"https://doi.org/10.1158/1541-7786.22515198","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.22515198","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9074000120162964}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2886048414","https://openalex.org/W4392699887","https://openalex.org/W3032234624","https://openalex.org/W2112609258","https://openalex.org/W2117768564","https://openalex.org/W3143680120","https://openalex.org/W2110290265","https://openalex.org/W2171313739","https://openalex.org/W1967532542","https://openalex.org/W2254809110"],"abstract_inverted_index":{"Supplemental":[0],"Table":[1],"2:":[2],"The":[3],"signaling":[4],"impact":[5,38,72],"of":[6,128],"IGF1R":[7],"activation":[8],"in":[9,26,32,47,58,97,100],"sensitive":[10,76,101],"vs.":[11,102],"resistant":[12,88,103],"cell":[13,34,77,89],"lines":[14,78],"for":[15,86,105],"all":[16,75,87],"analytes":[17],"examined":[18],"by":[19,42,54,81],"RPPA.":[20],"RPPA":[21],"was":[22,40,79,110],"performed":[23],"as":[24],"described":[25],"the":[27,44,55,69,82,94,114],"Methods.":[28],"For":[29,64],"each":[30,33,65],"protein":[31,45,56,66,98],"line,":[35],"an":[36],"IGF":[37],"ratio":[39,73,85,92],"calculated":[41],"dividing":[43],"level":[46,57,99],"cells":[48,59,104],"treated":[49,60],"with":[50,61,119],"EGFR-TKI":[51,62,108],"plus":[52],"desIGF1":[53],"alone.":[63],"and":[67,109],"EGFR-TKI,":[68],"average":[70,84],"IGF1":[71],"across":[74],"divided":[80],"same":[83],"lines;":[90],"this":[91],"represents":[93],"relative":[95],"change":[96],"a":[106],"given":[107],"rank-ordered":[111],"to":[112],"identify":[113],"proteins":[115],"most":[116],"likely":[117],"associated":[118],"IGF1R-based":[120],"treatment":[121],"resistance.":[122],"Amino":[123],"acid":[124],"residues":[125],"indicate":[126],"sites":[127],"phosphorylation.":[129]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-06T00:00:00"}